The Germany-based pharmaceutical company is facing more than 18,000 lawsuits linked to its Roundup herbicide, acquired in 2018 when it bought chemical giant Monsanto.
While Bayer has proposed $6 billion to $8 billion to resolve the lawsuits, plaintiffs’ lawyers want more than $10 billion, according to the report.
Negotiations have advanced to the point that lawyers for the plaintiffs and Bayer have asked two judges in St. Louis to postpone a trial that is set to begin this month.
Read the full report here.
More articles on pharmacy:
2020 election brewing ‘perfect storm’ for drug-pricing reform, analyst says
Colombia fines Pfizer $25K for drug price inflation
Jefferson Healthcare opens retail specialty pharmacy
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
